SNY has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Sanofi's quarterly accounts payable declined from Dec. 2013 ($13,384 Mil) to Jun. 2014 ($4,386 Mil) but then increased from Jun. 2014 ($4,386 Mil) to Dec. 2014 ($4,502 Mil).
Sanofi's annual accounts payable declined from Dec. 2012 ($4,186 Mil) to Dec. 2013 ($4,119 Mil) but then increased from Dec. 2013 ($4,119 Mil) to Dec. 2014 ($4,502 Mil).
Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.
It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
Sanofi Annual Data
Sanofi Quarterly Data